Rahim Nosrati at Guilan University of Medical Sciences, Iran.
Dr. Rahim Nosrati is a distinguished researcher in nanomedicine, drug delivery, and environmental microbiology. His contributions include patents on biofertilizers, novel biosensors, and nanoparticle-based drug delivery systems. Recognized for his impactful publications, he has received multiple awards, including Guilan University’s Top Researcher Award (2022). His work bridges biotechnology and pharmaceuticals, driving innovation in cancer diagnostics and microbial applications.
Publication Profile
Scopus
Orcid
Google Scholar
Educational Details
Dr. Rahim Nosrati holds a Ph.D. in Pharmaceutical Biotechnology from Mashhad University of Medical Sciences, Iran (2015-2021), with a distinguished thesis focusing on targeted drug delivery using superparamagnetic nanoparticles (SPION). He earned his M.S. in Microbiology from Shahed University (2009-2012), where he specialized in the isolation and characterization of phosphate-solubilizing and nitrogen-fixing bacteria. His academic journey began with a B.S. in Microbiology from Isfahan University (2005-2009).
Professional Experience
Dr. Nosrati is currently the Manager and Supervisor of the Student Research Committee at Guilan University of Medical Sciences, Iran. He previously served as an R&D Manager at Arman Zistfan Salamat Company (2013-2015) and Laboratory Supervisor at the FDA-accredited Microbiology & Probiotic Lab in Tehran. His research expertise extends to roles as a Researcher and Lab Technician at the Molecular Microbiology Research Center (MMRC), Shahed University (2012-2014).
Research Interest
Dr. Nosrati’s research focuses on:
Author Metrics
Citations 2085
h-index 24
i10-index 32
Top Noted Publication
1. SELEX Methods on the Road to Protein Targeting with Nucleic Acid Aptamers
Authors: P. Bayat, R. Nosrati, M. Alibolandi, H. Rafatpanah, K. Abnous, M. Khedri, …
📌 Journal: Biochimie
📌 Volume: 154
📌 Pages: 132-155
📌 Year: 2018
📌 Citations: 240
📌 DOI: [Insert DOI if available]
📌 Summary: This review explores advancements in Systematic Evolution of Ligands by Exponential Enrichment (SELEX), focusing on how nucleic acid aptamers are used to target proteins for applications in drug delivery, diagnostics, and therapeutics.
2. Aptamer-Based Biosensors and Nanosensors for the Detection of Vascular Endothelial Growth Factor (VEGF): A Review
📌 Authors: S. Dehghani, R. Nosrati, M. Yousefi, A. Nezami, F. Soltani, S.M. Taghdisi, …
📌 Journal: Biosensors and Bioelectronics
📌 Volume: 110
📌 Pages: 23-37
📌 Year: 2018
📌 Citations: 182
📌 DOI: [Insert DOI if available]
📌 Summary: This paper reviews aptamer-based biosensors and nanosensors developed for detecting VEGF, a crucial biomarker in cancer progression and angiogenesis, highlighting recent advances in biosensing technologies for early diagnosis.
3. Lung Cancer-Associated Brain Metastasis: Molecular Mechanisms and Therapeutic Options
📌 Authors: M. Yousefi, T. Bahrami, A. Salmaninejad, R. Nosrati, P. Ghaffari, S.H. Ghaffari
📌 Journal: Cellular Oncology
📌 Volume: 40(5)
📌 Pages: 419-441
📌 Year: 2017
📌 Citations: 168
📌 DOI: [Insert DOI if available]
📌 Summary: Discusses the molecular pathways involved in lung cancer brain metastases, evaluating targeted therapies and novel treatment strategies to improve patient outcomes.
4. Organ-Specific Metastasis of Breast Cancer: Molecular and Cellular Mechanisms Underlying Lung Metastasis
📌 Authors: M. Yousefi, R. Nosrati, A. Salmaninejad, S. Dehghani, A. Shahryari, A. Saberi
📌 Journal: Cellular Oncology
📌 Volume: 41(2)
📌 Pages: 123-140
📌 Year: 2018
📌 Citations: 152
📌 DOI: [Insert DOI if available]
📌 Summary: Provides an in-depth analysis of the molecular and cellular mechanisms that drive breast cancer metastasis to the lungs, presenting potential therapeutic interventions.
5. Aptasensors as a New Sensing Technology Developed for the Detection of MUC1 Mucin: A Review
📌 Authors: M. Yousefi, S. Dehghani, R. Nosrati, H. Zare, M. Evazalipour, J. Mosafer, …
📌 Journal: Biosensors and Bioelectronics
📌 Volume: 130
📌 Pages: 1-19
📌 Year: [Insert Year]
📌 Citations: [Insert Citation Count]
📌 DOI: [Insert DOI if available]
📌 Summary: Reviews the development of aptasensors for detecting MUC1 mucin, a cancer biomarker, with a focus on their potential applications in non-invasive cancer diagnostics.
Conclusion
Dr. Rahim Nosrati is a highly deserving candidate for the Best Researcher Award, given his pioneering contributions in nanomedicine, biosensors, and drug delivery. His high-impact publications, patents, and leadership roles reflect a strong research portfolio. With further global collaborations and funding initiatives, his contributions will continue to shape the future of biomedical research and nanotechnology applications.